BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li B, Wang L, Lu Q, Da W. Liver injury attenuation by curcumin in a rat NASH model: an Nrf2 activation-mediated effect? Ir J Med Sci. 2016;185:93-100. [PMID: 25385666 DOI: 10.1007/s11845-014-1226-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Heritage M, Jaskowski L, Bridle K, Campbell C, Briskey D, Britton L, Fletcher L, Vitetta L, Subramaniam VN, Crawford D. Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice. World J Gastrointest Pathophysiol 2017; 8(2): 67-76 [PMID: 28573069 DOI: 10.4291/wjgp.v8.i2.67] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 John P, Kale PP. Prominence of Oxidative Stress in the Management of Anti-tuberculosis Drugs Related Hepatotoxicity. DML 2020;13:95-101. [DOI: 10.2174/1872312813666190716155930] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ahsan R, Arshad M, Khushtar M, Ahmad MA, Muazzam M, Akhter MS, Gupta G, Muzahid M. A Comprehensive Review on Physiological Effects of Curcumin. Drug Res (Stuttg) 2020;70:441-7. [DOI: 10.1055/a-1207-9469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mirhafez SR, Azimi-Nezhad M, Dehabeh M, Hariri M, Naderan RD, Movahedi A, Abdalla M, Sathyapalan T, Sahebkar A. The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial. Adv Exp Med Biol 2021;1308:25-35. [PMID: 33861434 DOI: 10.1007/978-3-030-64872-5_3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Zhao M, Chen S, Ji X, Shen X, You J, Liang X, Yin H, Zhao L. Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease. Pharmacol Res 2021;166:105517. [PMID: 33636349 DOI: 10.1016/j.phrs.2021.105517] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Goldstein A, Soroka Y, Frušić-zlotkin M, Lewis A, Kohen R. The bright side of plasmonic gold nanoparticles; activation of Nrf2, the cellular protective pathway. Nanoscale 2016;8:11748-59. [DOI: 10.1039/c6nr02113a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
7 Hemmati-dinarvand M, saedi S, Valilo M, Kalantary-charvadeh A, Alizadeh Sani M, Kargar R, Safari H, Samadi N. Oxidative stress and Parkinson’s disease: conflict of oxidant-antioxidant systems. Neuroscience Letters 2019;709:134296. [DOI: 10.1016/j.neulet.2019.134296] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
8 Sang L, Wang XM, Xu DY, Sang LX, Han Y, Jiang LY. Morin enhances hepatic Nrf2 expression in a liver fibrosis rat model. World J Gastroenterol 2017; 23(47): 8334-8344 [PMID: 29307993 DOI: 10.3748/wjg.v23.i47.8334] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
9 Taguchi K, Kensler TW. Nrf2 in liver toxicology. Arch Pharm Res 2020;43:337-49. [PMID: 31782059 DOI: 10.1007/s12272-019-01192-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
10 Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020;9:E875. [PMID: 32260126 DOI: 10.3390/cells9040875] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 24.5] [Reference Citation Analysis]
11 Tong C, Wu H, Gu D, Li Y, Fan Y, Zeng J, Ding W. Effect of curcumin on the non-alcoholic steatohepatitis via inhibiting the M1 polarization of macrophages. Hum Exp Toxicol 2021;:9603271211038741. [PMID: 34470535 DOI: 10.1177/09603271211038741] [Reference Citation Analysis]
12 Geng S, Wang S, Zhu W, Xie C, Li X, Wu J, Zhu J, Jiang Y, Yang X, Li Y, Chen Y, Wang X, Meng Y, Zhu M, Wu R, Huang C, Zhong C. Curcumin attenuates BPA-induced insulin resistance in HepG2 cells through suppression of JNK/p38 pathways. Toxicology Letters 2017;272:75-83. [DOI: 10.1016/j.toxlet.2017.03.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
13 Ghafouri-fard S, Shoorei H, Bahroudi Z, Hussen BM, Talebi SF, Taheri M, Ayatollahi SA. Nrf2-Related Therapeutic Effects of Curcumin in Different Disorders. Biomolecules 2022;12:82. [DOI: 10.3390/biom12010082] [Reference Citation Analysis]
14 Afrin MR, Arumugam S, Pitchaimani V, Karuppagounder V, Thandavarayan RA, Harima M, Hossain CF, Suzuki K, Sone H, Matsubayashi Y, Watanabe K. Le Carbone prevents liver damage in non-alcoholic steatohepatitis-hepatocellular carcinoma mouse model via AMPKα-SIRT1 signaling pathway activation. Heliyon 2021;7:e05888. [PMID: 33490669 DOI: 10.1016/j.heliyon.2020.e05888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Jadeja RN, Upadhyay KK, Devkar RV, Khurana S. Naturally Occurring Nrf2 Activators: Potential in Treatment of Liver Injury. Oxid Med Cell Longev 2016;2016:3453926. [PMID: 28101296 DOI: 10.1155/2016/3453926] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 10.8] [Reference Citation Analysis]
16 Saadati S, Hatami B, Yari Z, Shahrbaf MA, Eghtesad S, Mansour A, Poustchi H, Hedayati M, Aghajanpoor-Pasha M, Sadeghi A, Hekmatdoost A. The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease. Eur J Clin Nutr 2019;73:441-9. [PMID: 30610213 DOI: 10.1038/s41430-018-0382-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
17 Farzaei MH, Zobeiri M, Parvizi F, El-Senduny FF, Marmouzi I, Coy-Barrera E, Naseri R, Nabavi SM, Rahimi R, Abdollahi M. Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective. Nutrients 2018;10:E855. [PMID: 29966389 DOI: 10.3390/nu10070855] [Cited by in Crossref: 105] [Cited by in F6Publishing: 89] [Article Influence: 26.3] [Reference Citation Analysis]
18 Nabavi SF, Barber AJ, Spagnuolo C, Russo GL, Daglia M, Nabavi SM, Sobarzo-Sánchez E. Nrf2 as molecular target for polyphenols: A novel therapeutic strategy in diabetic retinopathy. Crit Rev Clin Lab Sci 2016;53:293-312. [PMID: 26926494 DOI: 10.3109/10408363.2015.1129530] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
19 Mehta J, Rayalam S, Wang X. Cytoprotective Effects of Natural Compounds against Oxidative Stress. Antioxidants (Basel) 2018;7:E147. [PMID: 30347819 DOI: 10.3390/antiox7100147] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
20 Petersen DR, Saba LM, Sayin VI, Papagiannakopoulos T, Schmidt EE, Merrill GF, Orlicky DJ, Shearn CT. Elevated Nrf-2 responses are insufficient to mitigate protein carbonylation in hepatospecific PTEN deletion mice. PLoS One 2018;13:e0198139. [PMID: 29799837 DOI: 10.1371/journal.pone.0198139] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
21 Casas-Grajales S, Muriel P. Antioxidants in liver health. World J Gastrointest Pharmacol Ther 2015; 6(3): 59-72 [PMID: 26261734 DOI: 10.4292/wjgpt.v6.i3.59] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 47] [Article Influence: 8.3] [Reference Citation Analysis]
22 Qiu L, Guo C. Natural Aldose Reductase Inhibitor: A Potential Therapeutic Agent for Non-alcoholic Fatty Liver Disease. Curr Drug Targets 2020;21:599-609. [PMID: 31589122 DOI: 10.2174/1389450120666191007111712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
23 Ashrafizadeh M, Ahmadi Z, Mohammadinejad R, Farkhondeh T, Samarghandian S. Curcumin Activates the Nrf2 Pathway and Induces Cellular Protection Against Oxidative Injury. Curr Mol Med 2020;20:116-33. [PMID: 31622191 DOI: 10.2174/1566524019666191016150757] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 24.0] [Reference Citation Analysis]
24 Costa MC, Lima TFO, Arcaro CA, Inacio MD, Batista-duharte A, Carlos IZ, Spolidorio LC, Assis RP, Brunetti IL, Baviera AM. Trigonelline and curcumin alone, but not in combination, counteract oxidative stress and inflammation and increase glycation product detoxification in the liver and kidney of mice with high-fat diet-induced obesity. The Journal of Nutritional Biochemistry 2020;76:108303. [DOI: 10.1016/j.jnutbio.2019.108303] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
25 Qin J, He Y, Duan M, Luo M. Effects of Nuclear Factor-E2-related factor 2/Heme Oxygenase 1 on splanchnic hemodynamics in experimental cirrhosis with portal hypertension. Microvasc Res. 2017;111:12-19. [PMID: 28025064 DOI: 10.1016/j.mvr.2016.12.009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Casas-grajales S, Muriel P. The Liver, Oxidative Stress, and Antioxidants. Liver Pathophysiology. Elsevier; 2017. pp. 583-604. [DOI: 10.1016/b978-0-12-804274-8.00043-6] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]